The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vasilyev D.K.

National Medical Research Center for Therapy and Preventive Medicine

Bogdanova N.L.

National Medical Research Center for Therapy and Preventive Medicine

Gumanova N.G.

National Medical Research Center for Therapy and Preventive Medicine

Intercellular adhesion proteins — cadherin P, E, H and peripheral atherosclerosis

Authors:

Vasilyev D.K., Bogdanova N.L., Gumanova N.G.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(10): 67‑74

Read: 180 times


To cite this article:

Vasilyev DK, Bogdanova NL, Gumanova NG. Intercellular adhesion proteins — cadherin P, E, H and peripheral atherosclerosis. Russian Journal of Preventive Medicine. 2025;28(10):67‑74. (In Russ.)
https://doi.org/10.17116/profmed20252810167

Recommended articles:
Reclassification of ischemic heart disease epidemiological criteria. Russian Journal of Preventive Medi­cine. 2024;(12):61-68
Radionuclide methods in analysis of myocardial perfusion and meta­bolic acti­vity. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(4):12-19

References:

  1. Gaisenok OV. What is hidden behind the gender differences of carotid atherosclerosis? Russian Open Medical Journal. 2022;11:e0203. https://doi.org/10.15275/rusomj.2022.0203
  2. Garganeeva AA, Kuzheleva EA, Tukish OV, et al. Low-grade inflammation in prognosis in patients undergoing coronary artery bypass grafting: The importance of neutrophil-to-lymphocyte ratio and growth differentiation factor 15. Russian Open Medical Journal. 2025;14:e0107. https://doi.org/10.15275/rusomj.2025.0107
  3. Gumanova NG. Nitric oxide and its circulating NOx metabolites, their role in human body functioning and cardiovascular death risk prediction (part I). Russian Journal of Preventive Medicine. 2021;24(9):102-109. (In Russ.). https://doi.org/10.17116/profmed202124091102
  4. Gumanova NG. Nitrogen oxide and its circulating NOx metabolites, their role in human body functioning and cardiovascular death risk prediction (Part II). Russian Journal of Preventive Medicine. 2021;24(10):119-125. (In Russ.). https://doi.org/10.17116/profmed202124101119
  5. Gumanova NG, Vasilyev DK, Bogdanova NL, et al. P-, E-, and H-cadherins differ in their relationships with coronary stenosis, cardiovascular outcomes, and unplanned recurrent revascularization. Journal of Molecular and Cellular Cardiology Plus. 2024;9:100091. https://doi.org/10.1016/j.jmccpl.2024.100091
  6. Gumanova NG, Vasilyev DK, Bogdanova NL, et al. Serum Level of Cadherin-P (CDH3) Is a Novel Predictor of Cardiovascular Events Related to Atherosclerosis in a 3-Year Follow-Up Study. Journal of Clinical Medicine. 2024;13(21):6293. https://doi.org/10.3390/jcm13216293
  7. Santulli G, Varzideh F, Qin Y, et al. Circulating levels of cadherins are associated with atherosclerosis and cardiovascular outcomes. Journal of Molecular and Cellular Cardiology Plus. 2024;10:100092. https://doi.org/10.1016/j.jmccpl.2024.100092
  8. Huang Z, Zhou L, Duan J, et al. Oxidative Stress Promotes Liver Cancer Metastasis via RNF25-Mediated E-Cadherin Protein Degradation. Advanced Science. 2024;11(13):e2306929. https://doi.org/10.1002/advs.202306929
  9. Hazan RB, Qiao R, Keren R, et al. Cadherin switch in tumor progression. Annals of the New York Academy of Sciences. 2004;1014:155-163.  https://doi.org/10.1196/annals.1294.016
  10. Ma W, Hu J. Downregulated CDH3 is correlated with a better prognosis for LUAD and decreases proliferation and migration of lung cancer cells. Genes and Genomics. 2024;46(6):713-731.  https://doi.org/10.1007/s13258-023-01476-5
  11. Patel IS, Madan P, Getsios S, et al. Cadherin switching in ovarian cancer progression. International Journal of Cancer. 2003;106(2):172-177.  https://doi.org/10.1002/ijc.11086
  12. Dasen B, Vlajnic T, Mengus C, et al. T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance. Journal of Clinical Pathology. 2016;3(1):44-57.  https://doi.org/10.1002/cjp2.61
  13. Grimsley-Myers CM, Isaacson RH, Cadwell CM, et al. VE-cadherin endocytosis controls vascular integrity and patterning during development. Journal of Cell Biology. 2020;219(5):e201909081. https://doi.org/10.1083/jcb.201909081
  14. Davis MJ. Perspective: physiological role(s) of the vascular myogenic response. Microcirculation. 2012;19(2):99-114.  https://doi.org/10.1111/j.1549-8719.2011.00131.x
  15. Task Force Members, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology [published correction appears in European Heart Journal. 2014;35(33):2260-2261. European Heart Journal. 2013;34(38):2949-3003. https://doi.org/10.1093/eurheartj/eht296
  16. Zhatkina MV, Gavrilova NE, Makarova YuK, et al. Diagnosis of multifocal atherosclerosis using the Celermajer test. Kardiovaskuljarnaja terapija i profilaktika. 2020;19(5):2638. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2638
  17. Aboyans V, Ricco J-B, Marie-Louise EL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: The European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018;39:763-816. 
  18. Gao M, Hua Y, Zhao X, et al. Optimal Ultrasound Criteria for Grading Stenosis of the Superficial Femoral Artery. Ultrasound in Medicine and Biology. 2018;44(2):350-358.  https://doi.org/10.1016/j.ultrasmedbio.2017.10.001
  19. Nan W, He Y, Wang S, et al. Molecular mechanism of VE-cadherin in regulating endothelial cell behaviour during angiogenesis. Frontiers in Physiology. 2023;14:1234104. https://doi.org/10.3389/fphys.2023.1234104
  20. Zasadkevich YuM, Brilliant AA, Sazonov SV. Role of cadherins in health and in developing breast cancer. Russian Journal of Archive of Pathology. 2015;77(3):57-64. (In Russ.). https://doi.org/10.17116/patol201577357-64
  21. Baygildina AA. Pathogenetic significance of VE-cadherin at hemorrhagic fever with renal syndrome. Vestnik Udmurtskogo universiteta. 2017;27(3):322-331. (In Russ.).
  22. Wakasugi R, Suzuki K, Kaneko-Kawano T. Molecular Mechanisms Regulating Vascular Endothelial Permeability. International Journal of Molecular Sciences. 2024;25(12):6415. https://doi.org/10.3390/ijms25126415
  23. Potente M, Mäkinen T. Vascular Heterogeneity and Specialization in Development and Disease. Nature Reviews. Molecular Cell Biology. 2017;18:477-494.  https://doi.org/10.1038/nrm.2017.36
  24. Sweeney MD, Zhao Z, Montagne A, et al. Blood-Brain Barrier: From Physiology to Disease and Back. Physiological Reviews. 2019;99:21-78.  https://doi.org/10.1152/physrev.00050.2017
  25. Claesson-Welsh L, Dejana E, McDonald DM. Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies. Trends in Molecular Medicine. 2021;27:314-331.  https://doi.org/10.1016/j.molmed.2020.11.006
  26. Breviario F, Caveda L, Corada M, et al. Functional Properties of Human Vascular Endothelial Cadherin (7B4/Cadherin-5), an Endothelium-Specific Cadherin. Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1229-1239. https://doi.org/10.1161/01.atv.15.8.1229
  27. Souilhol C, Harmsen MC, Evans PC, et al. Endothelial-mesenchymal Transition in Atherosclerosis. Cardiovascular Research. 2018;114:565-577.  https://doi.org/10.1093/cvr/cvx253
  28. Liang G, Wang S, Shao J, et al. Tenascin-X Mediates Flow-Induced Suppression of EndMT and Atherosclerosis. Circulation Research. 2022;130(11): 1647-1659. https://doi.org/10.1161/CIRCRESAHA.121.320694
  29. Li Y, Wu Y, Qin X, et al. Constructing a competitive endogenous RNA network of EndMT-related atherosclerosis through weighted gene co-expression network analysis. Frontiers in Cardiovascular Medicine. 2024;10:1322252. https://doi.org/10.3389/fcvm.2023.1322252
  30. Elhenawy YI, Abdelmaksoud AA, Ismail EAR, et al. E-cadherin as a surrogate marker of epithelial-to-mesenchymal transition for detection of diabetic nephropathy and subclinical atherosclerosis among children and adolescents with type 1 diabete. Expert Review of Endocrinology and Metabolism. 2025;20(4):327-333.  https://doi.org/10.1080/17446651.2025.2492762
  31. Loh CY, Chai JY, Tang TF, et al. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges. Cells. 2019;8(10):1118. https://doi.org/10.3390/cells8101118
  32. Tao M, Shan L, Zhang W, et al. METTL3-mediated m6A modification of EGR1 mRNA promotes T2DM vasculopathy. Cellular Signalling. 2025; 127:111564. https://doi.org/10.1016/j.cellsig.2024.111564
  33. Okita T, Kita S, Fukuda S, et al. Soluble T-cadherin secretion from endothelial cells is regulated via insulin/PI3K/Akt signalling. Biochemical and Biophysical Research Communications. 2024;732:150403. https://doi.org/10.1016/j.bbrc.2024.150403
  34. Li M, Hu X, Hu X, et al. Inhibition of PHB1/PHB2 suppresses atherosclerotic plaque formation by interrupting PI3K/AKT/mTOR signaling. PLoS One. 2025;20(4):e0320509. https://doi.org/10.1371/journal.pone.0320509
  35. Vergadi E, Ieronymaki E, Lyroni K, et al. Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization. Journal of Immunology. 2017; 198(3):1006-1014. https://doi.org/10.4049/jimmunol.1601515
  36. Zhguleva AS, Zementova MS, Selkov SA, et al. M1/M2 macrophages: origin, phenotype, methods of production, interaction with natural killer cells and trophoblast. Medicinskaja immunologija. 2024;26(3):425-448. (In Russ.). https://doi.org/10.15789/1563-0625-MMO-2877
  37. López-Peláez M, Soria-Castro I, Boscá L, et al. Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression. European Journal of Immunology. 2011;41(6):1733-1741. https://doi.org/10.1002/eji.201041101

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.